State University of New York, Syracuse   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Syracuse NY United States (1834)

Organization Overview

First Clinical Trial
1996
NCT00002819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ajeet Gajra | State University of New York - Upstate Medical University | State University of New York, Upstate Medical University - Department of Psychiatry | State University of New York, Upstate Medical University (SUNY-UMU) | SUNY Upstate | SUNY Upstate Medical University | SUNY Upstate Medical University, Department of Psychiatry | SUNY Upstate Medical University, Psychiatry Department | SUNY Upstate Medical University, Psychiatry Dept. | SUNY Upstate Medical University - Syracuse, NY | SUNY Upstate Medical Unversity | SUNY Upstate UH | Upstate Medical Univeristy Syracuse | Upstate Medical University, State University of New York (SUNY) | Upstate Medical University, SUNY

Active Ingredients

Drugs in Phase 4 Trials (14)

armodafinil (nuvigil) (1 trial)

atovaquone (mepron) (1 trial)

chloroquine (1 trial)

cyclobenzaprine (flexeril) (1 trial)

doxycycline (vibramycin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

naltrexone (revia) (4 trials)

onabotulinumtoxinA (Botox) (1 trial)

proguanil (1 trial)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (2 trials)

ribavirin (virazole) (1 trial)

spironolactone (aldactone) (1 trial)

tiagabine (gabitril) (1 trial)

varenicline (chantix) (1 trial)

Drugs in Phase 3 Trials (16)

autologous hematopoietic stem cells (1 trial)

bone autograft (1 trial)

carboplatin (paraplatin) (5 trials)

cetuximab (erbitux) (2 trials)

cisplatin (platinol) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

diphenhydramine (benadryl) (1 trial)

doxepin (sinequan) (1 trial)

etoposide (vepesid) (1 trial)

idursulfase (elaprase) (1 trial)

lithium (lithonate) (1 trial)

memantine (namenda) (1 trial)

metformin (glucophage) (1 trial)

mitoxantrone (novantrone) (1 trial)

paclitaxel (taxol) (6 trials)

riluzole (rilutek) (2 trials)

Drugs in Phase 2 Trials (19)

acetylcysteine (mucomyst) (1 trial)

aprepitant (Emend) (1 trial)

arimoclomol (2 trials)

aripiprazole (abilify) (1 trial)

belinostat (beleodaq) (1 trial)

chromium tripicolinate (1 trial)

clarithromycin (biaxin) (1 trial)

creatine (1 trial)

dextromethorphan (delsym) (1 trial)

lenalidomide (revlimid) (1 trial)

metyrosine (demser) (1 trial)

pomalidomide (pomalyst) (1 trial)

quinidine (1 trial)

sirolimus (rapamune) (2 trials)

sodium oxybate (xyrem) (1 trial)

stem cells (1 trial)

tamoxifen (nolvadex) (1 trial)

tirasemtiv (4 trials)

urea (2 trials)

Drugs in Phase 1 Trials (10)

amifostine (ethyol) (1 trial)

amiloride (midamor) (1 trial)

bifidobacterium animalis (1 trial)

bupivacaine (Exparel) (1 trial)

denv-1-lvhc (3 trials)

denv-3-lvhc (2 trials)

rivaroxaban (xarelto) (1 trial)

tdenv-f17 (1 trial)

tdenv-piv (1 trial)

valproic acid (depakene) (1 trial)

Drugs in Other Trials (11)

acamprosate (campral) (1 trial)

calcium (1 trial)

cephalexin (keflex) (1 trial)

fish oil (Omegavan) (1 trial)

linseed oil (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

methylprednisolone (medrol) (1 trial)

mupirocin (bactroban) (1 trial)

olive (1 trial)

risedronate (actonel) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 4)

Alcohol-Related Disorders (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 3)

Anxiety Disorders (Phase 4)

Bipolar Disorder (Phase 4)

Body Weight (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Dengue (Phase 1)

Depression (Phase 2)

Depressive Disorder (Phase 2)

DiGeorge Syndrome (Phase 2)

Disease (Phase 4)

Fatigue (Phase 4)

Fibromyalgia (Phase 4)

Headache (Phase 4)

Head and Neck Neoplasms (Phase 2)

Heart Failure (Phase 4)

Hematuria (Phase 1)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Liver Diseases (Phase 4)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 2)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Mental Disorders (Phase 4)

Migraine Disorders (Phase 4)

Motor Neuron Disease (Phase 3)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Multiple Myeloma (Phase 2)

Myofascial Pain Syndromes (Phase 4)

Neoplasms, Plasma Cell (Phase 2)

Ovarian Neoplasms (Phase 3)

Pain, Postoperative (Phase 1)

Phobia, Social (Phase 3)

Psychotic Disorders (Phase 4)

Rabies (Phase 4)

Schizophrenia (Phase 4)

Sclerosis (Phase 3)

Sleep Initiation and Maintenance Disorders (Phase 2)

Small Cell Lung Carcinoma (Phase 3)

Stress Disorders, Post-Traumatic (Phase 2)

Substance-Related Disorders (Phase 4)

Syndrome (Phase 3)

Tobacco Use Disorder (Phase 4)

Urinary Bladder Neoplasms (Phase 1)

Vomiting (Phase 2)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 60
  • # of Trial APIs: 70